Cargando…

Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease

BACKGROUND: Atrial fibrillation (AF) is a strong risk factor for Alzheimer’s disease (AD) independent of ischemic stroke. However, the clinicopathological impact of AF on the severity of AD has not been well elucidated. We aimed to investigate the clinical differences between dementia patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakase, Taizen, Tatewaki, Yasuko, Thyreau, Benjamin, Odagiri, Hayato, Tomita, Naoki, Yamamoto, Shuzo, Takano, Yumi, Muranaka, Michiho, Taki, Yasuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838038/
https://www.ncbi.nlm.nih.gov/pubmed/36635728
http://dx.doi.org/10.1186/s13195-023-01165-1
_version_ 1784869199856795648
author Nakase, Taizen
Tatewaki, Yasuko
Thyreau, Benjamin
Odagiri, Hayato
Tomita, Naoki
Yamamoto, Shuzo
Takano, Yumi
Muranaka, Michiho
Taki, Yasuyuki
author_facet Nakase, Taizen
Tatewaki, Yasuko
Thyreau, Benjamin
Odagiri, Hayato
Tomita, Naoki
Yamamoto, Shuzo
Takano, Yumi
Muranaka, Michiho
Taki, Yasuyuki
author_sort Nakase, Taizen
collection PubMed
description BACKGROUND: Atrial fibrillation (AF) is a strong risk factor for Alzheimer’s disease (AD) independent of ischemic stroke. However, the clinicopathological impact of AF on the severity of AD has not been well elucidated. We aimed to investigate the clinical differences between dementia patients with AF and those without AF by means of imaging data. METHODS: Following approval from the institutional ethics committee, patients with newly diagnosed AD or amnestic mild cognitive impairment (aMCI) were retrospectively screened (n = 170, 79.5 ± 7.4 years old). Cognitive function was assessed using the Mini-Mental State Examination (MMSE). Based on the MRI data, the cerebral volume, cerebral microbleeds (CMBs), periventricular white matter lesions (WMLs), and deep WMLs were evaluated. The regional cerebral blood flow (rCBF) was measured using (123)I-IMP SPECT. RESULTS: Of the patients, 14 (8.2%) and 156 (91.8%) had AF (AF group) and sinus rhythm (SR group), respectively. The AF group had significantly lower MMSE scores than the SR group (average [standard deviation (SD)]: 19.4 [4.4] and 22.0 [4.4], respectively; p = 0.0347). Cerebral volume and CMBs did not differ between the two groups. The periventricular WMLs, but not the deep WMLs, were significantly larger in the AF group than in the SR group (mean [SD] mL: 6.85 [3.78] and 4.37 [3.21], respectively; p = 0.0070). However, there was no significant difference in rCBF in the areas related to AD pathology between the two groups. CONCLUSION: AD and aMCI patients with AF showed worse cognitive decline along with larger periventricular WMLs compared to those with SR, although the reduction of rCBF was not different between patients with AF and SR. The white matter lesions may be a more important pathology than the impairment of cerebral blood flow in dementia patients with AF. A larger study is needed to confirm our findings in the future. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01165-1.
format Online
Article
Text
id pubmed-9838038
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98380382023-01-14 Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease Nakase, Taizen Tatewaki, Yasuko Thyreau, Benjamin Odagiri, Hayato Tomita, Naoki Yamamoto, Shuzo Takano, Yumi Muranaka, Michiho Taki, Yasuyuki Alzheimers Res Ther Research BACKGROUND: Atrial fibrillation (AF) is a strong risk factor for Alzheimer’s disease (AD) independent of ischemic stroke. However, the clinicopathological impact of AF on the severity of AD has not been well elucidated. We aimed to investigate the clinical differences between dementia patients with AF and those without AF by means of imaging data. METHODS: Following approval from the institutional ethics committee, patients with newly diagnosed AD or amnestic mild cognitive impairment (aMCI) were retrospectively screened (n = 170, 79.5 ± 7.4 years old). Cognitive function was assessed using the Mini-Mental State Examination (MMSE). Based on the MRI data, the cerebral volume, cerebral microbleeds (CMBs), periventricular white matter lesions (WMLs), and deep WMLs were evaluated. The regional cerebral blood flow (rCBF) was measured using (123)I-IMP SPECT. RESULTS: Of the patients, 14 (8.2%) and 156 (91.8%) had AF (AF group) and sinus rhythm (SR group), respectively. The AF group had significantly lower MMSE scores than the SR group (average [standard deviation (SD)]: 19.4 [4.4] and 22.0 [4.4], respectively; p = 0.0347). Cerebral volume and CMBs did not differ between the two groups. The periventricular WMLs, but not the deep WMLs, were significantly larger in the AF group than in the SR group (mean [SD] mL: 6.85 [3.78] and 4.37 [3.21], respectively; p = 0.0070). However, there was no significant difference in rCBF in the areas related to AD pathology between the two groups. CONCLUSION: AD and aMCI patients with AF showed worse cognitive decline along with larger periventricular WMLs compared to those with SR, although the reduction of rCBF was not different between patients with AF and SR. The white matter lesions may be a more important pathology than the impairment of cerebral blood flow in dementia patients with AF. A larger study is needed to confirm our findings in the future. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01165-1. BioMed Central 2023-01-13 /pmc/articles/PMC9838038/ /pubmed/36635728 http://dx.doi.org/10.1186/s13195-023-01165-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Nakase, Taizen
Tatewaki, Yasuko
Thyreau, Benjamin
Odagiri, Hayato
Tomita, Naoki
Yamamoto, Shuzo
Takano, Yumi
Muranaka, Michiho
Taki, Yasuyuki
Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
title Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
title_full Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
title_fullStr Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
title_full_unstemmed Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
title_short Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
title_sort impact of atrial fibrillation on the cognitive decline in alzheimer’s disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838038/
https://www.ncbi.nlm.nih.gov/pubmed/36635728
http://dx.doi.org/10.1186/s13195-023-01165-1
work_keys_str_mv AT nakasetaizen impactofatrialfibrillationonthecognitivedeclineinalzheimersdisease
AT tatewakiyasuko impactofatrialfibrillationonthecognitivedeclineinalzheimersdisease
AT thyreaubenjamin impactofatrialfibrillationonthecognitivedeclineinalzheimersdisease
AT odagirihayato impactofatrialfibrillationonthecognitivedeclineinalzheimersdisease
AT tomitanaoki impactofatrialfibrillationonthecognitivedeclineinalzheimersdisease
AT yamamotoshuzo impactofatrialfibrillationonthecognitivedeclineinalzheimersdisease
AT takanoyumi impactofatrialfibrillationonthecognitivedeclineinalzheimersdisease
AT muranakamichiho impactofatrialfibrillationonthecognitivedeclineinalzheimersdisease
AT takiyasuyuki impactofatrialfibrillationonthecognitivedeclineinalzheimersdisease